← Human Trials & Peer-Reviewed Studies
Fish Oil and Vitamin D Supplementations in Pregnancy Protect Against Childhood Croup.
Plain-language guide to PMID 36184023 (2023): double-blind randomized controlled trial of Vitamin D, K2, Magnesium and Zinc in 736 women.
Key Facts
- PMID
- 36184023
- Journal
- The journal of allergy and clinical immunology. In practice
- Year
- 2023
- Study type
- Randomized Controlled Trial
- Authors
- Brustad N et al. (7 authors)
- DOI
- 10.1016/j.jaip.2022.09.027
- Registered trial
- NCT00798226, NCT00856947
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of Vitamin D, K2, Magnesium and Zinc, published as a randomized controlled trial.
Croup is a prevalent respiratory disorder in early childhood most often caused by parainfluenza virus infections.
Who Took Part
The abstract describes 736 women taking part.
PubMed indexes the participants as young children, women only.
The study was completed in the Danish population-based single-center Copenhagen Prospective Studies on Asthma in Childhood 2010 mother-child cohort, which included 736 pregnant women.
How the Study Was Run
In design terms this was a randomized and double-blind study.
The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.
Neither the women nor the staff measuring them knew who was on Vitamin D, K2, Magnesium and Zinc, so expectations could not easily colour the readings.
Croup was diagnosed by physicians' clinical examinations and medical record checks.
Potential mediating mechanisms were investigated using blood metabolomics, airway cytokines, and airway microbiome.
What Was Measured
Topics PubMed links to this paper include Fish Oils, Croup, Olive Oil, Fatty Acids, Omega-3, Dietary Supplements, Vitamins and Vitamin D.
Author keywords: COPSAC, PUFA and RCT.
What This Means in Plain Language
The paper is a randomized and double-blind study of Vitamin D, K2, Magnesium and Zinc in 736 women.
With several hundred people or more, it is a fairly large study for this kind of research.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2023 (The journal of allergy and clinical immunology. In practice), a journal based in United States.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.